MORRISVILLE, N.C.--(BUSINESS WIRE)--Aug. 8, 2006--Trimeris, Inc. (NASDAQ: TRMS - News): Trimeris, Inc. (NASDAQ: TRMS - News) today announced financial results for the three months ending June 30, 2006, reporting total revenues of $7.3 million, an increase of 66 percent, compared to the same period last year. This increase was primarily driven by strong North American sales of FUZEON, which reached $31.1 million, a growth of 23 percent over the same period last year. All sales of FUZEON are recorded by F. Hoffmann-La Roche Ltd., (“Roche”), Trimeris’ collaborative partner.
